Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
about
Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseasesPhysiological roles of aquaporin-4 in brainTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesAggregation state determines the localization and function of M1- and M23-aquaporin-4 in astrocytesOptic neuritis in neuromyelitis optica.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Aquaporin-4 autoantibodies increase vasogenic edema formation and infarct size in a rat stroke modelLarge-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.Aquaporins: important but elusive drug targets.Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis opticaBiology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.The treatment of neuromyelitis optica.Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificityThe intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer modelPathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.Aquaporin water channels in the nervous system.Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.Greatly improved survival and neuroprotection in aquaporin-4-knockout mice following global cerebral ischemia.Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.Regulation and Function of AQP4 in the Central Nervous System.Aquaporins in Nervous System.Aquaporin-Targeted Therapeutics: State-of-the-Field.Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica.Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.Aquaporin modulators: a patent review (2010-2015).
P2860
Q26860077-34ABA491-A200-4CE0-AAB3-24FEFF626AA6Q26866009-7C782636-81C6-4565-A1F4-6160D4CCED6DQ28245749-41B32692-46A6-4CF8-9916-A70D76F35057Q30572079-7ABF66A2-44CF-491F-A904-B42F2766746FQ30610471-94171FFA-4961-4F7E-8B1C-367DC1CDEEF7Q30785267-F739DC34-FC81-4ABE-A8F4-7C304D89F4CAQ30953714-19F29054-8C1D-4049-A2BD-BC6788591569Q33567268-4B2C47C2-DD28-4F3D-B70B-97088FD82C2EQ33792739-3208B503-3506-4146-8CD6-E62B080CA970Q34338762-BF13566F-EC07-40D5-92BB-3EA67E507904Q34377212-C55B9129-FF94-404C-80F9-311F3B836CAEQ34399291-D5A3E67C-149C-472D-BF44-4DCF2838A61AQ34497097-AA099991-B531-49CB-AFFE-54F17040B86DQ35048235-B5191E27-EC4E-4195-BDF2-414BF22126C0Q35242214-EC4456B8-E948-4F1A-8D8C-B0C4DD1640C9Q35626822-3B4342E0-4D2A-432F-B3DF-5FA99D19237FQ37066291-BE9B7C08-31F3-494C-B9B9-8B37DF0ED5D4Q37353732-CB15AD0F-78A1-41F4-8789-E6DF11ABD3BDQ37503646-ECDF4970-1015-4F0C-8B01-66A07B74F7E9Q38235026-C4DA6867-A16F-43ED-998B-EF884B655ED7Q38335788-081D7ACB-383A-430B-A2CF-0B1D8E695E27Q38750890-E5349EF2-E4B5-472F-8A00-163F2F8B5962Q39160830-3A99DB6A-0668-4714-BF7D-ED10D684FBB0Q40092095-E34B4DD3-5414-4840-8749-3B71372BF84DQ41163269-FADFDD5B-6EB2-4F9C-B2C2-0023F2152808Q42272997-7DCA8492-B411-4B86-BE72-4F7E8E26B905Q42844764-C45C270D-5FC1-4C2A-B7FC-DA7FE9920BCCQ44945605-8E77BAE0-7FD3-4972-BD6E-DBF37262F4DAQ46591339-52578359-D0A1-4728-A9E3-5842371659C1Q48172406-1636F211-2201-4202-A09E-129834185906Q51512961-8247C316-66C5-44E6-AB25-4B1353F0BBDC
P2860
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@ast
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@en
type
label
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@ast
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@en
prefLabel
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@ast
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@en
P2093
P2860
P356
P1433
P1476
Neuromyelitis optica IgG does ...... t, or supramolecular assembly.
@en
P2093
A S Verkman
Andrea Rossi
Jeffrey L Bennett
Julien Ratelade
Marios C Papadopoulos
P2860
P304
P356
10.1002/GLIA.22417
P577
2012-09-14T00:00:00Z